Published in BMC Dev Biol on February 21, 2010
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease. Immune Netw (2011) 1.29
Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis (2013) 0.92
miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs. PLoS One (2011) 0.84
miRNA regulation of cytotoxic effects in mouse Sertoli cells exposed to nonylphenol. Reprod Biol Endocrinol (2011) 0.83
Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish. Neurotoxicol Teratol (2013) 0.80
Effects of short-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on microRNA expression in zebrafish embryos. Toxicol Appl Pharmacol (2012) 0.78
Bone loss in adult offspring induced by low-dose exposure to teratogens. J Bone Miner Metab (2011) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
The functions of animal microRNAs. Nature (2004) 64.85
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
The role of site accessibility in microRNA target recognition. Nat Genet (2007) 18.52
Tumor spectrum analysis in p53-mutant mice. Curr Biol (1994) 16.60
microRNA functions. Annu Rev Cell Dev Biol (2007) 15.74
Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell (2005) 15.38
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell (2007) 14.58
Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol (2008) 12.35
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell (2007) 9.51
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol (2007) 8.05
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol (2007) 6.87
Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol (2001) 6.73
Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA (2007) 6.44
miRBase: the microRNA sequence database. Methods Mol Biol (2006) 6.17
Cell death in development. Cell (1999) 6.01
Canalization of development by microRNAs. Nat Genet (2006) 5.46
Control of apoptosis by p53. Oncogene (2003) 4.46
MicroRNA-125b is a novel negative regulator of p53. Genes Dev (2009) 4.43
A microRNA imparts robustness against environmental fluctuation during development. Cell (2009) 4.08
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A (2007) 4.04
miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta (2009) 3.28
microRNAs: a safeguard against turmoil? Cell (2007) 3.11
The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res (2007) 2.92
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ (2009) 2.80
miRNAs and apoptosis: RNAs to die for. Oncogene (2006) 2.80
microRNAs and cancer: an overview. Cell Cycle (2008) 2.80
MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle (2009) 2.71
MicroRNAs and cell cycle regulation. Cell Cycle (2007) 2.62
p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat Med (1996) 2.13
Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology (2002) 1.90
Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis. Genes Dev (2002) 1.89
A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet (1995) 1.75
Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells. EMBO J (2002) 1.73
MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther (2008) 1.48
Retinoic acid downregulates microRNAs to induce abnormal development of spinal cord in spina bifida rat model. Childs Nerv Syst (2007) 1.09
Shhh! Silencing by microRNA-155. Philos Trans R Soc Lond B Biol Sci (2009) 1.02
Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr Biol (1996) 0.97
Cyclophosphamide teratogenesis: a review. Teratog Carcinog Mutagen (1985) 0.96
Tiny actors, great roles: microRNAs in p53's service. Cell Cycle (2007) 0.92
Integrative genomic analyses on GLI2: mechanism of Hedgehog priming through basal GLI2 expression, and interaction map of stem cell signaling network with P53. Int J Oncol (2008) 0.89
The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations. Development (1998) 0.89
Cyclophosphamide-induced teratogenesis in ICR mice: the role of apoptosis. Teratog Carcinog Mutagen (1995) 0.83
TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol (2003) 0.83
Immunoteratology: I. MHC involvement in the embryo response to teratogens in mice. Am J Reprod Immunol (1995) 0.82
Embryotoxic effects of CKD-602, a new camptothecin anticancer agent, in rats. Reprod Toxicol (2005) 0.81
Influence of cyclophosphamide and 4-ketocyclophosphamide on mouse limb development. Teratology (1977) 0.80
Teratogen-induced apoptotic cell death: does the apoptotic machinery act as a protector of embryos exposed to teratogens? Birth Defects Res C Embryo Today (2005) 0.80
p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding. Reproduction (2007) 0.80
Prenatal radiation-induced limb defects mediated by Trp53-dependent apoptosis in mice. Radiat Res (2000) 0.80
Differential effects of 4-hydroperoxycyclophosphamide on limb development in vitro. Teratology (1986) 0.77
Teratogen-induced distortions in the classical NF-kappaB activation pathway: correlation with the ability of embryos to survive teratogenic stress. Toxicol Appl Pharmacol (2008) 0.76
Cell death in normal and abnormal development. Congenit Anom (Kyoto) (2008) 0.76
Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA (2007) 6.44
Canalization of development by microRNAs. Nat Genet (2006) 5.46
The birth of an alternatively spliced exon: 3' splice-site selection in Alu exons. Science (2003) 5.04
Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol (2011) 2.62
Identification of let-7-regulated oncofetal genes. Cancer Res (2008) 2.56
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Recognition of unknown conserved alternatively spliced exons. PLoS Comput Biol (2005) 1.77
Inference of splicing regulatory activities by sequence neighborhood analysis. PLoS Genet (2006) 1.71
MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. Proc Natl Acad Sci U S A (2009) 1.67
Renal apoptosis following carbon dioxide pneumoperitoneum in a rat model. J Urol (2008) 1.51
Pathogen detection using short-RNA deep sequencing subtraction and assembly. Bioinformatics (2011) 1.43
miRNAkey: a software for microRNA deep sequencing analysis. Bioinformatics (2010) 1.41
Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res Dev Brain Res (2003) 1.38
Recycling to the plasma membrane is delayed in EHD1 knockout mice. Traffic (2006) 1.37
Systematic identification of edited microRNAs in the human brain. Genome Res (2012) 1.35
Analysis of insertion-deletion from deep-sequencing data: software evaluation for optimal detection. Brief Bioinform (2012) 1.35
Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein. Stem Cells (2012) 1.29
miRNAminer: a tool for homologous microRNA gene search. BMC Bioinformatics (2008) 1.21
Feed-forward microprocessing and splicing activities at a microRNA-containing intron. PLoS Genet (2011) 1.18
Familial pityriasis rubra pilaris is caused by mutations in CARD14. Am J Hum Genet (2012) 1.16
Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli. Mol Syst Biol (2011) 1.13
microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn. J Cell Sci (2013) 1.12
MicroRNA pharmacogenomics: post-transcriptional regulation of drug response. Trends Mol Med (2011) 1.12
Pax6 regulates gene expression in the vertebrate lens through miR-204. PLoS Genet (2013) 1.11
The U1 snRNP base pairs with the 5' splice site within a penta-snRNP complex. Mol Cell Biol (2003) 1.10
A gastrolith protein serving a dual role in the formation of an amorphous mineral containing extracellular matrix. Proc Natl Acad Sci U S A (2008) 1.09
Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One (2011) 1.07
Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells. J Biol Chem (2011) 1.03
Species-specific microRNA roles elucidated following astrocyte activation. Nucleic Acids Res (2011) 1.02
Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells. PLoS One (2012) 1.00
miRviewer: a multispecies microRNA homologous viewer. BMC Res Notes (2012) 0.98
Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome. Nucleic Acids Res (2014) 0.98
MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients. Neurobiol Dis (2013) 0.97
The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p. Cell Mol Neurobiol (2013) 0.95
Versatility of MicroRNA biogenesis. PLoS One (2011) 0.93
Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia. Hum Mutat (2007) 0.93
Genome-wide miRNA expression profiling of human lymphoblastoid cell lines identifies tentative SSRI antidepressant response biomarkers. Pharmacogenomics (2012) 0.93
Pharmaco-miR: linking microRNAs and drug effects. Brief Bioinform (2013) 0.92
The origin of human mesenchymal stromal cells dictates their reparative properties. J Am Heart Assoc (2013) 0.91
Biased exonization of transposed elements in duplicated genes: A lesson from the TIF-IA gene. BMC Mol Biol (2007) 0.91
Characterization of coding synonymous and non-synonymous variants in ADAMTS13 using ex vivo and in silico approaches. PLoS One (2012) 0.91
The microRNA Transcriptome of Human Cytomegalovirus (HCMV). Open Virol J (2012) 0.90
Biased hosting of intronic microRNA genes. Bioinformatics (2010) 0.90
Roles for Dicer1 in the patterning and differentiation of the optic cup neuroepithelium. Development (2011) 0.88
Ab initio identification of functionally interacting pairs of cis-regulatory elements. Genome Res (2008) 0.88
Bioactivation of carbamate-based 20(S)-camptothecin prodrugs. Bioorg Med Chem (2004) 0.86
Evaluation of optimization techniques for variable selection in logistic regression applied to diagnosis of myocardial infarction. Bioinformation (2009) 0.85
Next-generation sequencing of small RNAs from inner ear sensory epithelium identifies microRNAs and defines regulatory pathways. BMC Genomics (2014) 0.84
NF-kappa B DNA-binding activity in embryos responding to a teratogen, cyclophosphamide. BMC Dev Biol (2002) 0.84
Species-specific microRNA regulation influences phenotypic variability: perspectives on species-specific microRNA regulation. Bioessays (2013) 0.84
Vaccinia virus infection suppresses the cell microRNA machinery. Arch Virol (2012) 0.84
Novel insight into the non-coding repertoire through deep sequencing analysis. Nucleic Acids Res (2012) 0.84
TNF-alpha protects embryos exposed to developmental toxicants. Am J Reprod Immunol (2003) 0.83
Characterization of a novel murine retrovirus mixture that facilitates hematopoiesis. J Virol (2002) 0.83
Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers. Breast Cancer Res Treat (2013) 0.83
MiR-192 directly binds and regulates Dicer1 expression in neuroblastoma. PLoS One (2013) 0.82
MicroRNAs: fundamental regulators of gene expression in major affective disorders and suicidal behavior? Front Cell Neurosci (2013) 0.82
Regulation of transcription of the RNA splicing factor hSlu7 by Elk-1 and Sp1 affects alternative splicing. RNA (2007) 0.82
Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients. J Mol Neurosci (2015) 0.81
Whole-exome sequencing in individuals with multiple cardiovascular risk factors and normal coronary arteries. Coron Artery Dis (2016) 0.81
Cole Disease Results from Mutations in ENPP1. Am J Hum Genet (2013) 0.80
p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-kappaB DNA binding. Reproduction (2007) 0.80
Teratogen-induced apoptotic cell death: does the apoptotic machinery act as a protector of embryos exposed to teratogens? Birth Defects Res C Embryo Today (2005) 0.80
MicroRNAs in the growth plate are responsive to nutritional cues: association between miR-140 and SIRT1. J Nutr Biochem (2012) 0.80
RNA-binding protein PTB and microRNA-221 coregulate AdipoR1 translation and adiponectin signaling. Diabetes (2013) 0.79
Conservation of expression and alternative splicing in the prosaposin gene. Brain Res Mol Brain Res (2004) 0.79
Genome-wide transcriptomic variations of human lymphoblastoid cell lines: insights from pairwise gene-expression correlations. Pharmacogenomics (2012) 0.79
Does base-pairing strength play a role in microRNA repression? RNA (2012) 0.79
The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion. Mol Cell Biol (2005) 0.79
Potentiation of the maternal immune system may modify the apoptotic process in embryos exposed to developmental toxicants. Am J Reprod Immunol (2003) 0.78
Toxicogenomic analysis of a sustained release local anesthetic delivery system. Biomaterials (2012) 0.78
Pharmacogenomics genes show varying perceptibility to microRNA regulation. Pharmacogenet Genomics (2011) 0.78
Meeting summary: Ethical aspects of whole exome and whole genome sequencing studies (WES/WGS) in rare diseases, Tel Aviv, Israel, January 2013. Genet Res (Camb) (2013) 0.78
Exome sequencing analysis: a guide to disease variant detection. Methods Mol Biol (2013) 0.78
Assembly algorithms for deep sequencing data: basics and pitfalls. Methods Mol Biol (2013) 0.77
Mechanisms of the embryo's response to embryopathic stressors: a focus on p53. J Reprod Immunol (2010) 0.77
Missense mutation in the MEN1 gene discovered through whole exome sequencing co-segregates with familial hyperparathyroidism. Genet Res (Camb) (2013) 0.77
MicroRNA-34a is dispensable for p53 function as teratogenesis inducer. Arch Toxicol (2014) 0.76
Teratogen-induced distortions in the classical NF-kappaB activation pathway: correlation with the ability of embryos to survive teratogenic stress. Toxicol Appl Pharmacol (2008) 0.76
Differential teratogenic response of TNFalpha+/+ and TNFalpha-/- mice to cyclophosphamide: the possible role of NF-kappaB. Birth Defects Res A Clin Mol Teratol (2006) 0.76
Cancer, senescence, and aging: translation from basic research to clinics. J Aging Res (2011) 0.76
Genetics research: jumping into the deep end of the pool. Genet Res (Camb) (2013) 0.76